Amplexd Therapeutics
PrivateLast Round
Seed
May 20, 2024
Total Funding Raised
$2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Amplexd Therapeutics is a biotechnology company that develops non-invasive, accessible therapies for HPV-induced cervical intraepithelial neoplasia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplexd Therapeutics Comparables
Compare Amplexd Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antiva Biosciences | 84% | |
| Frantz Medical Group | 82% | |
| Gynion | 78% |
Amplexd Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 20, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 681% MoM, reaching 1.6K.
Amplexd Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amplexd Therapeutics's valuation, stock price, and market status.
Is Amplexd Therapeutics a public or private company?
Amplexd Therapeutics is a private company.
What is the current stock price of Amplexd Therapeutics?
Amplexd Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Amplexd Therapeutics worth (valuation)?
Valuation information for Amplexd Therapeutics is not publicly available.
Can I buy Amplexd Therapeutics stock?
Amplexd Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amplexd Therapeutics's last funding round?
Amplexd Therapeutics's most recent funding round was Seed on May 20, 2024.
Who are the main investors in Amplexd Therapeutics?
Investor information for Amplexd Therapeutics is not publicly disclosed.
Will Amplexd Therapeutics IPO soon?
No public IPO plans have been announced for Amplexd Therapeutics.
How can I track Amplexd Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amplexd Therapeutics's secondary market activity and sign up for updates.